|
TIPIN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.942200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.358400E-02 |
| Normal-vs-Stage2 |
9.024000E-01 |
| Normal-vs-Stage3 |
5.758600E-01 |
| Normal-vs-Stage4 |
7.422600E-01 |
| Stage1-vs-Stage2 |
2.428400E-01 |
| Stage1-vs-Stage3 |
3.395000E-03 |
| Stage1-vs-Stage4 |
1.412990E-01 |
| Stage2-vs-Stage3 |
5.785200E-01 |
| Stage2-vs-Stage4 |
8.871800E-01 |
| Stage3-vs-Stage4 |
3.420400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.746400E-01 |
| Normal-vs-AfricanAmerican |
8.870800E-01 |
| Normal-vs-Asian |
6.686800E-01 |
| Caucasian-vs-AfricanAmerican |
5.289400E-01 |
| Caucasian-vs-Asian |
9.294200E-01 |
| AfricanAmerican-vs-Asian |
7.272000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.670800E-01 |
| Normal-vs-Female |
3.399400E-01 |
| Male-vs-Female |
6.885200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.479200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.601400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.085000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.421800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.697200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.441400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.526800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.212800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.920400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.756000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.437500E-03 |
| Normal-vs-Grade 2 |
8.668100E-02 |
| Normal-vs-Grade 3 |
8.823000E-01 |
| Normal-vs-Grade 4 |
4.718400E-01 |
| Grade 1-vs-Grade 2 |
6.410100E-02 |
| Grade 1-vs-Grade 3 |
3.316700E-03 |
| Grade 1-vs-Grade 4 |
2.997500E-03 |
| Grade 2-vs-Grade 3 |
2.071900E-02 |
| Grade 2-vs-Grade 4 |
1.015680E-02 |
| Grade 3-vs-Grade 4 |
2.858800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.377100E-03 |
| Normal-vs-ccB subtype |
3.353200E-01 |
| ccA subtype-vs-ccB subtype |
3.31680000020818E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.582000E-01 |
| Normal-vs-N1 |
9.443200E-01 |
| N0-vs-N1 |
6.821600E-01 |
|
|
